Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-15-000353
Filing Date
2015-02-02
Accepted
2015-02-02 18:46:55
Documents
1
Period of Report
2015-02-01

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5899
  Complete submission text file 0001493152-15-000353.txt   7541
Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042
Imprimis Pharmaceuticals, Inc. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130
Business Address
SAHAREK JOHN P. (Reporting) CIK: 0001632091 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 15568749